Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer

Clinical trial NCT00124930 · TERMINATED

Trial details

NCT number: NCT00124930
Sponsor: Alberta Health services
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Nausea Neoplasms

Start date: 2005-05-01
Primary completion: 2008-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.